Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ABBVIE INC. Stock Hits Forecast Price Target with 13.9% Profit

February 06, 2024
On December 19, 2023, QuantWave's forecast signal for ABBVIE INC. indicated a long position with the stock priced at $144.21. This forecast proved to be highly accurate as the target price of $164.25 was reached on February 6, 2024, resulting in a profitable return of 13.9%.

The successful achievement of the price target showcases the effectiveness of QuantWave's analytics in predicting market movements. Factors such as positive earnings reports and developments in the pharmaceutical industry likely contributed to ABBVIE INC.'s upward trajectory during this period.

QuantWave, an automated forecasting platform, provides users with access to predictions for various stocks, presenting opportunities for profitable trades. For those seeking to enhance their investment strategy, QuantSchool offers educational resources on utilizing the QuantWave forecasting system to generate consistent income.

Overall, the accurate forecast for ABBVIE INC. exemplifies the potential benefits of utilizing QuantWave's predictive analytics for informed investment decisions.
If you want to leave a comment, then you need Login or Register





Other data for ABBV

Related data

ABBVMarch 22, 2025AbbVie ABBV Stock Moves -0.29: What You Should Know  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, has recently experienced a slight decrease in stock movement. As an investor, it is essential to keep track of such fluctuations....


ABBVMarch 20, 2025AbbVie Inc. ABBV is Experiencing Global Investor Interest: A Look into the Company's Success Story  ~2 min.

AbbVie Inc., a renowned pharmaceutical company, has been making waves in the global market, attracting significant attention from investors worldwide....


ABBVMarch 19, 2025AbbVie Inc. ABBV: A Higher-Yielding Healthcare Play That Continues to Shine  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, is steadily gaining the attention of investors. With its continuous success in the healthcare industry, AbbVie has become a top choice for hedge funds....


ABBVMarch 18, 2025The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell, and Hamilton Beach Brands  ~1 min.

According to a recent analysis by Zacks, AbbVie Inc. (ABBV) is considered one of the top healthcare stocks to invest in....


ABBVMarch 14, 2025AbbVie Inc. ABBV is Attracting Investor Attention: Here is What You Should Know  ~2 min.

AbbVie Inc. (ABBV) has been grabbing the attention of investors recently with its impressive performance in the healthcare sector....


ABBVMarch 10, 2025ABBVIE INC. Hits Price Target Forecast with 15.28% Profit – A Triumph for QuantWave's Analytics  ~1 min.

ABBVIE INC. achieved a significant milestone as it hit the price target forecast set by QuantWave, resulting in a profit of 15.28%....


ABBVMarch 10, 2025ABBVIE INC. Hits Price Target Forecast on QuantWave with 15.28% Profit Margin  ~1 min.

AbbVie Inc. (ABBV) has successfully reached the price target forecast on QuantWave, signaling a profitable long position for investors. The forecast, initiated on August 13, 2024, at a price of $184....


ABBVFebruary 28, 2025QuantWave Forecast Success: ABBVIE INC. Hits Price Target with 13.87% Profit  ~2 min.

On July 30, 2024, QuantWave issued a long signal for ABBVIE INC. stock when it was priced at 180.33 $....


ABBVFebruary 28, 2025ABBVIE INC. Hits Price Target Forecast with 25.02% Profit on QuantWave  ~1 min.

QuantWave, the automated forecasting platform, recently achieved a significant milestone with its price target forecast for ABBVIE INC....


ABBVFebruary 27, 2025ABBVIE INC. Hits Price Target Forecast with 22.62% Profit Margin  ~1 min.

QuantWave's forecast for ABBVIE INC. proved to be spot on as the stock reached the predicted target with a profitable outcome of 22.62%....


REGNAugust 13, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 19.03% Profit – QuantWave Success Story  ~2 min.

REGENERON PHARMACEUTICALS, INC. (NASDAQ: REGN) has recently achieved its price target forecast as predicted by the automated forecasting platform, QuantWave....


REGNAugust 19, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 14.57% Profit Margin  ~1 min.

On July 2nd, 2024, QuantWave issued a forecast signal for REGENERON PHARMACEUTICALS, INC., predicting a long position when the stock was trading at 1041.78 $....


LLYJune 7, 2024ELI LILLY AND COMPANY Hits Price Target Forecast with 35.45% Profit, Reflecting QuantWave's Accuracy  ~2 min.

ELI LILLY AND COMPANY, a leading pharmaceutical company, recently achieved the price target forecast set by QuantWave with impressive results....


GSKFebruary 5, 20259.43% Profit Achieved: GSK PLC Hits Price Target Forecast on QuantWave  ~1 min.

On December 11, 2024, QuantWave's automated forecasting platform issued a long signal for GSK PLC with a price of $33.69....


NVOJanuary 31, 2024NOVO NORDISK A/S Hits Price Target Forecast with 11.64% Profit, Showcasing QuantWave's Accuracy  ~1 min.

NOVO NORDISK A/S recently reached the price target forecast set by QuantWave on 2023-11-21, signaling a long position at $100.05. On 2024-01-31, the stock hit the target price of $111....